Copyright
©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. May 7, 2005; 11(17): 2643-2646
Published online May 7, 2005. doi: 10.3748/wjg.v11.i17.2643
Published online May 7, 2005. doi: 10.3748/wjg.v11.i17.2643
Table 2 Distribution of 5-Fu-GCL in liver tumor (mean±SD, n = 10).
| Groups | Doses (mg/kg) | Content (mg/g) |
| Control | - | - |
| 5-Fu-GCL | 20 | 16.3±3.5 |
| 40 | 22.9±4.7a | |
| 80 | 28.3±5.9 | |
| Free 5-Fu | 40 | 18.3±3.2 |
- Citation: Jin Y, Li J, Rong LF, Li YH, Guo L, Xu SY. Anti-hepatocarcinoma effects of 5-fluorouracil encapsulated by galactosylceramide liposomes in vivo and in vitro. World J Gastroenterol 2005; 11(17): 2643-2646
- URL: https://www.wjgnet.com/1007-9327/full/v11/i17/2643.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i17.2643